Treatment for Carbon Footprint in Anesthetic

Phase-Based Progress Estimates
University of Alberta Hospital, Edmonton, Canada
Carbon Footprint in Anesthetic
All Sexes
What conditions do you have?

Study Summary

Following Ethics approval, all adult patients undergoing surgery to fix the wrist fracture will be approached and consent to undergo this study. The amount of waste generated from general anesthetic, regional anesthetic and regional+general anesthetic will be collected and weighed. Patients undergoing this type of wrist surgery have only regional anesthetic, or general anesthetic, or both ie. regional anesthetic and general anesthetic. The aim of the study is to compare the amount of waste generated from each type of anesthetic and this will give us a better idea of which anesthetic is more environmentally sustainable.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Carbon Footprint in Anesthetic

Study Objectives

2 Primary · 4 Secondary · Reporting Duration: intraoperative

During surgical intervention
Carbon dioxide emission
Duration of surgery
Generation of solid waste
Amount of carbon dioxide emission
duration of surgery
solid waste generated within the type of anesthetic

Trial Safety

Safety Progress

1 of 3

Other trials for Carbon Footprint in Anesthetic

Trial Design

0 Treatment Group

90 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: intraoperative
Closest Location: University of Alberta Hospital · Edmonton, Canada
Photo of university of alberta hospital  1Photo of university of alberta hospital  2Photo of university of alberta hospital  3
2009First Recorded Clinical Trial
1 TrialsResearching Carbon Footprint in Anesthetic
275 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.